Hematology

Trials, guidelines and clinical evidence across Hematology.

Elritercept Phase 3 Trial Targets Anemia in Myelofibrosis on Ruxolitinib

Takeda’s phase 3 ELRISE MF trial is testing elritercept against placebo to improve anemia, symptoms, and safety in myelofibrosis patients on ruxolitinib.

By Dr. Revathy Mohan V.R., MBBS · 4 days ago · 5 min read

Hematology·Nature

Baylor seeks postdoctoral associate for stem cell and leukemia research

Baylor College of Medicine is hiring a postdoctoral associate to study how hematopoietic stem cells acquire mutations and…

4 days ago

Hematology·Cancer Cell

Pot1a supports mesenchymal stem cell niche function for hematopoietic stem cells

Cell Reports study links Pot1a to mesenchymal stem cell niche function, positioning the protein as a key regulator…

4 days ago

Hematology·NLM Alerts

G6PD Genotypes and Hydroxychloroquine Risk by WHO Class

NCBI’s G6PD allele table maps hydroxychloroquine-relevant variants to WHO classes, helping clinicians gauge hemolysis risk across genotypes.

4 days ago

Hematology·Gut

Dasatinib GI Bleeding and Colitis Emerge as Underrecognized Toxicities

A narrative review links dasatinib to GI bleeding and colitis, with mechanisms, case examples, and the need for…

4 days ago

Hematology·PLOS Med

TERT Germline Variants Linked to Telomere Disorder Phenotypes and Mortality

A genome-first analysis linked deleterious TERT germline variants to telomere disorder phenotypes, shorter telomeres, and higher mortality signals.

4 days ago

Hematology·JACC

ASFA Updates Therapeutic Apheresis Guidelines Across 183 Indications

ASFA’s 10th evidence-based apheresis update reviews 93 fact sheets and 183 indications, refining how therapeutic apheresis should be…

5 days ago

Hematology·Front Immunol

CML Transplant Modified After Pneumonectomy and CNS Relapse

A refractory CML case details lung surgery for mucormycosis, CNS relapse, and successful reduced-intensity transplant with durable MRD…

6 days ago

Hematology·Nature

DECTIN1+ MDSCs Linked to MSC Benefit in Severe Aplastic Anemia

MSC coinfusion amplified DECTIN1+ MDSCs in haplo-HSCT for severe aplastic anemia, with STAT3-TNFAIP3 signaling tied to immune suppression.

6 days ago

Hematology·STAT

Sickle Cell Gene Therapy Revival Hints at a Narrower Clinical Path

A STAT teaser suggests renewed interest in a failed sickle cell gene therapy, but the accessible text omits…

Nov 6, 2026

Hematology

Trials, guidelines and clinical evidence across Hematology.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.